A reference set of clinically relevant adverse drug-drug interactions

The accurate and timely detection of adverse drug-drug interactions (DDIs) during the postmarketing phase is an important yet complex task with potentially major clinical implications. The development of data mining methodologies that scan healthcare databases for drug safety signals requires approp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kontsioti, Elpida, Maskell, Simon, Dutta, Bhaskar, Pirmohamed, Munir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Data Descriptor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897500/
https://www.ncbi.nlm.nih.gov/pubmed/35246559
http://dx.doi.org/10.1038/s41597-022-01159-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897500/
https://www.ncbi.nlm.nih.gov/pubmed/35246559
http://dx.doi.org/10.1038/s41597-022-01159-y

Ejemplares similares